165 related articles for article (PubMed ID: 31414232)
1. Resorption of the calcium phosphate layer on S53P4 bioactive glass by osteoclasts.
van Gestel NAP; Schuiringa GH; Hennissen JHPH; Delsing ACA; Ito K; van Rietbergen B; Arts JJ; Hofmann S
J Mater Sci Mater Med; 2019 Aug; 30(8):94. PubMed ID: 31414232
[TBL] [Abstract][Full Text] [Related]
2. In vitro Ca-P precipitation on biodegradable thermoplastic composite of poly(epsilon-caprolactone-co-DL-lactide) and bioactive glass (S53P4).
Jaakkola T; Rich J; Tirri T; Närhi T; Jokinen M; Seppälä J; Yli-Urpo A
Biomaterials; 2004 Feb; 25(4):575-81. PubMed ID: 14607495
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenic protein expression and bone formation are induced by bioactive glass S53P4 scaffolds in vivo.
Björkenheim R; Strömberg G; Ainola M; Uppstu P; Aalto-Setälä L; Hupa L; Pajarinen J; Lindfors NC
J Biomed Mater Res B Appl Biomater; 2019 Apr; 107(3):847-857. PubMed ID: 30194906
[TBL] [Abstract][Full Text] [Related]
4. Utilisation of bioactive glass S53P4 inside an induced membrane for severe bone defect with high risk of infection: a multi-center preliminary experience.
Aurégan JC; Villain B; Glombitza M; Blokhuis T; Heinänen M; Bégué T
Injury; 2022 Oct; 53 Suppl 2():S13-S19. PubMed ID: 35871084
[TBL] [Abstract][Full Text] [Related]
5. Sintered S53P4 bioactive glass scaffolds have anti-inflammatory properties and stimulate osteogenesis in vitro.
Björkenheim R; Jämsen E; Eriksson E; Uppstu P; Aalto-Setälä L; Hupa L; Eklund KK; Ainola M; Lindfors NC; Pajarinen J
Eur Cell Mater; 2021 Jan; 41():15-30. PubMed ID: 33389745
[TBL] [Abstract][Full Text] [Related]
6. In vitro surface reaction layer formation and dissolution of calcium phosphate cement-bioactive glass composites.
Liu C; Chen CW; Ducheyne P
Biomed Mater; 2008 Sep; 3(3):034111. PubMed ID: 18689928
[TBL] [Abstract][Full Text] [Related]
7. Mineralization of dentin induced by treatment with bioactive glass S53P4 in vitro.
Forsback AP; Areva S; Salonen JI
Acta Odontol Scand; 2004 Feb; 62(1):14-20. PubMed ID: 15124778
[TBL] [Abstract][Full Text] [Related]
8. A dual constant-composition titration system as an in vitro resorption model for comparing dissolution rates of calcium phosphate biomaterials.
Chow LC; Markovic M; Takagi S
J Biomed Mater Res B Appl Biomater; 2003 May; 65(2):245-51. PubMed ID: 12687717
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Growth Reduction of Five Clinical Pathogens by Injectable S53P4 Bioactive Glass Material Formulations.
Thijssen EGJ; van Gestel NAP; Bevers R; Hofmann S; Geurts J; van Loo IHM; Arts JJ
Front Bioeng Biotechnol; 2020; 8():634. PubMed ID: 32676498
[TBL] [Abstract][Full Text] [Related]
10. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.
Malat TA; Glombitza M; Dahmen J; Hax PM; Steinhausen E
Z Orthop Unfall; 2018 Apr; 156(2):152-159. PubMed ID: 29665602
[TBL] [Abstract][Full Text] [Related]
11. Effects of S53P4 bioactive glass on osteoblastic cell and biomaterial surface interaction.
Pérez-Tanoira R; Kinnari TJ; Hyyrynen T; Soininen A; Pietola L; Tiainen VM; Konttinen YT; Aarnisalo AA
J Mater Sci Mater Med; 2015 Oct; 26(10):246. PubMed ID: 26411442
[TBL] [Abstract][Full Text] [Related]
12. BAG-S53P4 as bone graft extender and antimicrobial activity against gentamicin- and vancomycin-resistant bacteria.
Bortolin M; Romanò CL; Bidossi A; Vecchi E; Mattina R; Drago L
Future Microbiol; 2018 Apr; 13():525-533. PubMed ID: 29521127
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis - Real-time assessment by isothermal microcalorimetry.
Gonzalez Moreno M; Butini ME; Maiolo EM; Sessa L; Trampuz A
Colloids Surf B Biointerfaces; 2020 May; 189():110853. PubMed ID: 32058256
[TBL] [Abstract][Full Text] [Related]
14. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study.
Drago L; Romanò D; De Vecchi E; Vassena C; Logoluso N; Mattina R; Romanò CL
BMC Infect Dis; 2013 Dec; 13():584. PubMed ID: 24325278
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro.
Coraça-Huber DC; Fille M; Hausdorfer J; Putzer D; Nogler M
J Orthop Res; 2014 Jan; 32(1):175-7. PubMed ID: 24108602
[TBL] [Abstract][Full Text] [Related]
16. Composition dependent mechanical behaviour of S53P4 bioactive glass putty for bone defect grafting.
van Gestel NAP; Hulsen DJW; Geurts J; Hofmann S; Ito K; Arts JJ; van Rietbergen B
J Mech Behav Biomed Mater; 2017 May; 69():301-306. PubMed ID: 28131065
[TBL] [Abstract][Full Text] [Related]
17. Bioactive glass S53P4 in repair of septal perforations and its interactions with the respiratory infection-associated microorganisms Haemophilus influenzae and Streptococcus pneumoniae.
Stoor P; Söderling E; Grénman R
J Biomed Mater Res; 2001; 58(1):113-20. PubMed ID: 11153007
[TBL] [Abstract][Full Text] [Related]
18. S53P4 bioactive glass scaffolds induce BMP expression and integrative bone formation in a critical-sized diaphysis defect treated with a single-staged induced membrane technique.
Eriksson E; Björkenheim R; Strömberg G; Ainola M; Uppstu P; Aalto-Setälä L; Leino VM; Hupa L; Pajarinen J; Lindfors NC
Acta Biomater; 2021 May; 126():463-476. PubMed ID: 33774197
[TBL] [Abstract][Full Text] [Related]
19. In vitro model for frontal sinus obliteration with bioactive glass S53P4.
Peltola MJ; Suonpää JT; Andersson H; Määttänen HS; Aitasalo KM; Yli-Urpo A; Laippala PJ
J Biomed Mater Res; 2000; 53(2):161-6. PubMed ID: 10713562
[TBL] [Abstract][Full Text] [Related]
20. Regeneration of Cystic Bone Cavities and Bone Defects With Bioactive Glass S53P4 in the Upper and Lower Jaws.
Stoor P; Apajalahti S; Kontio R
J Craniofac Surg; 2017 Jul; 28(5):1197-1205. PubMed ID: 28538076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
